SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.19-CN¥0.70 (-0.49%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.09% below the high.
Loading market information…
HKSE · 6618.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 06:24 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
JD Health International Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
JD Health International Inc.’s next earnings report is currently expected on Mar 29, 2027, with estimated earnings per share of HK$1.13. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow JD Health International Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:39 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2023 | Mar 20, 2024 | HK$0.59+22.7% vs estimate | HK$29.07B+2.09% vs estimate |
|---|
| Q2 2023 | Jun 30, 2023 | HK$0.53+28.33% vs estimate | HK$29.32B-2.31% vs estimate |
|---|
| Q4 2022 | Mar 22, 2023 | HK$0.28-20.21% vs estimate | HK$30.01B+8.07% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.19-CN¥0.70 (-0.49%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.09% below the high.
CN¥48.53-CN¥0.09 (-0.19%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.28% below the high.
HK$2.84+HK$0.08 (+2.9%)
Alibaba Health Information Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 64.16% below the high.
HK$5.41+HK$0.13 (+2.46%)
Ping An Healthcare and Technology Company Limited’s quoted price sits in the lower half of its reported 52-week range, 71.23% below the high.
HK$64.00-HK$0.50 (-0.78%)
Xunfei Healthcare Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.2% below the high.
HK$6.35+HK$0.03 (+0.4%)
Medlive Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.69% below the high.
HK$2.87-HK$0.06 (-1.88%)
Yidu Tech Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.29% below the high.
HK$1.00-HK$0.02 (-1.49%)
Fangzhou Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.02% below the high.
